Stockscreener 앱 받기
11.81
5.52%
-0.69
시장 영업 전:
11.59
-0.22
-1.86%
전일 마감가:
$12.50
열려 있는:
$12.53
하루 거래량:
2.13M
Relative Volume:
1.53
시가총액:
$898.60M
수익:
$11.40B
순이익/손실:
$-95.73M
주가수익비율:
-4.8204
EPS:
-2.45
순현금흐름:
$-64.37M
1주 성능:
-5.97%
1개월 성능:
+26.58%
6개월 성능:
+129.77%
1년 성능:
+128.43%
1일 변동 폭
$11.68
$12.65
1주일 범위
$11.68
$12.94
52주 변동 폭
$4.70
$12.94
Mind Medicine Inc Stock (MNMD) Company Profile
명칭
Mind Medicine Inc
전화
212-220-6633
주소
ONE WORLD TRADE CENTER, NEW YORK
MNMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
11.81 | 951.10M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-04 | 재개 | Oppenheimer | Outperform |
| 2025-01-28 | 개시 | Evercore ISI | Outperform |
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-10-14 | 재개 | Leerink Partners | Outperform |
| 2024-07-24 | 개시 | ROTH MKM | Buy |
| 2024-05-29 | 개시 | Robert W. Baird | Outperform |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | Canaccord Genuity | Buy |
| 2022-12-09 | 재개 | ROTH Capital | Buy |
| 2022-11-16 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-26 | 개시 | Oppenheimer | Outperform |
| 2022-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-04 | 개시 | ROTH Capital | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
모두보기
Mind Medicine Inc 주식(MNMD)의 최신 뉴스
Why Mind Medicine Stock Is Skyrocketing Today - AOL.com
Price action breakdown for Mind Medicine (MindMed) Inc.Options Play & Scalable Portfolio Growth Ideas - newser.com
Is this a good reentry point in Mind Medicine (MindMed) Inc.Watch List & Trade Opportunity Analysis Reports - newser.com
Can a trend reversal in Mind Medicine (MindMed) Inc. lead to recoveryJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
Is Mind Medicine (MindMed) Inc. stock ready for a breakoutJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
What MACD and RSI say about Mind Medicine (MindMed) Inc.July 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Is Mind Medicine (MindMed) Inc. meeting your algorithmic filter criteriaJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
Relative strength of Mind Medicine (MindMed) Inc. in sector analysisMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com
Using Bollinger Bands to evaluate Mind Medicine (MindMed) Inc.Breakout Watch & Safe Swing Trade Setups - newser.com
What drives Mind Medicine MindMed Inc stock priceTake Profit Strategies & Affordable Investment Tips - earlytimes.in
Mind Medicine (MindMed) (NASDAQ:MNMD) Reaches New 12-Month HighWhat's Next? - MarketBeat
Volatility clustering patterns for Mind Medicine (MindMed) Inc.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Is a relief rally coming for Mind Medicine (MindMed) Inc. holdersInflation Watch & Verified Stock Trade Ideas - newser.com
Will Mind Medicine (MindMed) Inc. (MMQ) stock deliver compounding returnsBear Alert & Verified Trade Idea Suggestions - newser.com
Is Mind Medicine (MindMed) Inc. (MMQ) stock trading at attractive multiplesJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 6.8%Should You Sell? - MarketBeat
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) high institutional ownership speaks for itself as stock continues to impress, up 26% over last week - Yahoo Finance
Mind Medicine (MindMed) (NASDAQ:MNMD) Hits New 12-Month HighShould You Buy? - MarketBeat
Published on: 2025-09-29 08:42:36 - earlytimes.in
MindMed projects 2026 trial readouts for pivotal MM120 studies in GAD and MDD - MSN
MEGMILK SNOW BRAND CoLtd 6MG Stock Analysis and ForecastEarnings Forecast Updates & Individual Stock Tracking Service - Early Times
Is Mind Medicine MindMed Inc a good long term investmentPrice Momentum Alerts & Free Trading Signals to Sharpen Your Edge - earlytimes.in
Is Mind Medicine (MindMed) Inc. showing signs of accumulation2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
Mind Medicine MindMed Inc Stock Analysis and ForecastMonthly Performance Summary & Easy Tools to Analyze Your Investment Risk - earlytimes.in
MindMed (MNMD) Stock: Top Executives Sell Over $362K in Shares as Stock Nears 52-Week High - CoinCentral
Mindmed: chief legal officer Sullivan sells $110k in shares By Investing.com - Investing.com Nigeria
MindMed (MNMD) CEO Barrow sells $252,036 in shares By Investing.com - Investing.com Australia
MindMed (MNMD) CMO Karlin sells $75k in shares By Investing.com - Investing.com Nigeria
MindMed (MNMD) CEO Barrow sells $252,036 in shares - Investing.com India
Mindmed: chief legal officer Sullivan sells $110k in shares - Investing.com India
Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Sells $75,268.08 in Stock - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) CEO Sells $252,036.69 in Stock - MarketBeat
MindMed (MNMD) CMO Karlin sells $75k in shares - Investing.com India
Mind Medicine Inc (MNMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mind Medicine Inc 주식 (MNMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Barrow Robert | Chief Executive Officer |
Sep 25 '25 |
Sale |
9.77 |
25,797 |
252,037 |
804,268 |
| Karlin Daniel | Chief Medical Officer |
Sep 25 '25 |
Sale |
9.77 |
7,704 |
75,268 |
430,625 |
5.74%
자본화:
|
볼륨(24시간):